Back to search

Ireland· IE-PA-PA0540/068/001

Rifinah 150/100 mg Film- Coated Tablets

A rifampicin and isoniazid product containing rifampicin + isoniazid, registered in Ireland by Sanofi-Aventis Ireland Limited T/A SANOFI. The same ATC class is registered in 9 of our 19 countries.

ATC J04AM02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedRifinah 150/100 mg Film- Coated Table…ATCJ04AM02REGISTER NO.IE-PA-PA0540/068/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Rifampicin and isoniazid is registered in 9 of 19 countries.

Countries holding a registration under ATC J04AM02 (rifampicin and isoniazid), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 5 of them publish a price we can compare per daily dose

Rifampicin and isoniazid · ATC J04AM02

9 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Rifampicin + Isoniazid
Manufacturer
Sanofi-Aventis Ireland Limited T/A SANOFI
Country
Ireland (IE)
ATC code
J04AM02
ATC class
Rifampicin and isoniazid
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0540/068/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

61 interactions on record for rifampicin and isoniazid.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rifampicin and isoniazid · interactions on record

61 records

61 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Rifampicin and isoniazid in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifampicin and isoniazid products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Rifoldin Mit Inh
  • Cyprus · Rifamazid
  • Denmark · Rimactazid
  • Spain · Rifinah
  • France · Rifinah
  • United Kingdom (Northern Ireland) · Rifinah
  • Greece · Rifinah
  • Hungary · Rifazid
  • Italy · Rifinah
  • Lithuania · Rifamazid
  • Netherlands · Rifinah
  • Norway · Rimactazid
  • Poland · Rifamazid
  • Portugal · Rifinah
  • Romania · Sinerdol Iso
  • Sweden · Rimactazid
  • Slovenia · Rifinah

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8c770e4d-7d0e-4383-9b86-ae6bff2e7e69
GET /v1/drugs/8c770e4d-7d0e-4383-9b86-ae6bff2e7e69?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "J04AM",
    "J04AM02"
  ],
  "strength": null,
  "pa_number": "PA0540/068/001",
  "substances": [
    "Rifampicin",
    "Isoniazid"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "01/04/1977",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about rifampicin and isoniazid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.